A Single Cycle of Rituximab for the Treatment of Severe Pemphigus | Zendy

P. Joly | Zendy; Hugo Mouquet | Zendy; JeanClaude Roujeau | Zendy; M. D’Incan | Zendy; Danièle Gilbert | Zendy; Serge Jacquot | Zendy; MarieLise Gougeon | Zendy; C. Bédane | Zendy; Ralf Müller | Zendy; Brigitte Dréno | Zendy; M.S. Doutre | Zendy; E. Delaporte | Zendy; Christine Pauwels | Zendy; Nathalie Franck | Zendy; F. Caux | Zendy; Catherine Picard | Zendy; Emmanuelle TancrèdeBohin | Zendy; Philippe Bernard | Zendy; François Tron | Zendy; Michael Hertl | Zendy; Philippe Musette | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Single Cycle of Rituximab for the Treatment of Severe Pemphigus

Author(s) -

P. Joly,

Hugo Mouquet,

JeanClaude Roujeau,

M. D’Incan,

Danièle Gilbert,

Serge Jacquot,

MarieLise Gougeon,

C. Bédane,

Ralf Müller,

Brigitte Dréno,

M.S. Doutre,

E. Delaporte,

Christine Pauwels,

Nathalie Franck,

F. Caux,

Catherine Picard,

Emmanuelle TancrèdeBohin,

Philippe Bernard,

François Tron,

Michael Hertl,

Philippe Musette

Publication year - 2007

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa067752

Subject(s) - rituximab , medicine , pemphigus , pemphigus vulgaris , dermatology , immunology , antibody

The combination of multiple cycles of rituximab and intravenous immune globulins has been reported to be effective in patients with severe pemphigus. The aim of this study was to assess the efficacy of a single cycle of rituximab in severe types of pemphigus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research